AMGN Amgen Inc
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
$238.04 +4.94 (2.12%)
As of 03/24/2023 15:59:55 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Large cap
GICS sector: Health Care
Industry: Drug Manufacturers—General
Index country: USA
Country of incorporation: USA
IPO date: 02/06/2001
Outstanding shares: 533,976,238
Average volume: 2,826,282
Market cap: $122,723,758,780
Current dividend yield: 3.42%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: 2023607
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%